The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 24, 2017

Filed:

Jun. 08, 2014
Applicant:

Rjs Biologics Llc, Seattle, WA (US);

Inventor:

Stephen McCraith, Seattle, WA (US);

Assignee:

RJS Biologics, Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/704 (2006.01); A61K 31/366 (2006.01); A61K 47/48 (2006.01); A61K 49/10 (2006.01); A61K 39/395 (2006.01); A61K 31/54 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48061 (2013.01); A61K 31/366 (2013.01); A61K 31/54 (2013.01); A61K 31/704 (2013.01); A61K 39/3955 (2013.01); A61K 49/106 (2013.01);
Abstract

There is disclosed a compound, a pharmaceutical composition and a method of treatment using a pharmaceutical composition comprising a tethering moiety that is capable of binding to a macrophage migration inhibitory factor (MIF) polypeptide, optionally linked to a linker moiety and further covalently bound to a drug moiety or imaging agent. More specifically, there is disclosed a genus of affinity-tethering moieties covalently bound to a drug moiety or imaging agent either directly or optionally via a linker moiety to covalently link the tethering moiety to a drug moiety. Without being bound by theory, the disclosed pharmaceutical compounds are targeted to cancer cells or immune cells via an affinity-tethering moiety that hitch-hikes to or into its target cell while bound to endogenous MIF.


Find Patent Forward Citations

Loading…